(BTI) British American Tobacco - Overview
Sector: Consumer DefensiveIndustry: Tobacco | Exchange NYSE (USA) | Currency USD | Market Cap: 128.138m | Total Return 52.7% in 12m
Stock: Tobacco, Vapour, Nicotine
Total Rating 64
Risk 71
Buy Signal -0.29
| Risk 5d forecast | |
|---|---|
| Volatility | 20.4% |
| Relative Tail Risk | -4.76% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.84 |
| Alpha | 48.17 |
| Character TTM | |
|---|---|
| Beta | -0.017 |
| Beta Downside | 0.143 |
| Drawdowns 3y | |
|---|---|
| Max DD | 19.29% |
| CAGR/Max DD | 1.44 |
EPS (Earnings per Share)
Revenue
Description: BTI British American Tobacco March 04, 2026
British American Tobacco p.l.c. (BTI) is a global tobacco and nicotine product company operating across North America, South America, Europe, Asia-Pacific, Africa, and the Middle East. The company’s business model involves manufacturing and distributing a diverse portfolio of products.
BTI’s product categories include vapor products, heated tobacco products, modern oral products (e.g., nicotine pouches), and traditional oral products (e.g., snus, moist snuff). The company also sells combustible products like cigarettes and fine-cut/roll-your-own tobacco. The tobacco industry is currently undergoing a significant transition from traditional combustible products to new categories like vapes and heated tobacco.
Key brands in BTI’s portfolio include Vuse, glo, Velo, Grizzly, Kodiak, Dunhill, Kent, Lucky Strike, Pall Mall, and Newport. Distribution primarily occurs through retail outlets. Understanding the competitive landscape and market share of these brands is crucial for analysts, and further research on ValueRay can provide detailed insights.
Headlines to watch out for
- Global combustible cigarette volume declines impact revenue
- Next-generation product growth offsets traditional tobacco decline
- Regulatory scrutiny on nicotine products increases compliance costs
- Currency fluctuations affect international sales and profitability
- Excise taxes on tobacco products erode profit margins
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 10.83b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.14 > 0.02 and ΔFCF/TA 1.12 > 1.0 |
| NWC/Revenue: -3.57% < 20% (prev -5.30%; Δ 1.73% < -1%) |
| CFO/TA 0.11 > 3% & CFO 12.38b > Net Income 10.83b |
| Net Debt (31.24b) to EBITDA (20.34b): 1.54 < 3 |
| Current Ratio: 0.87 > 1.5 & < 3 |
| Outstanding Shares: last fiscal year (2.20b) vs prev -1.17% < -2% |
| Gross Margin: 83.17% > 18% (prev 0.82%; Δ 8.24k% > 0.5%) |
| Asset Turnover: 45.03% > 50% (prev 34.28%; Δ 10.74% > 0%) |
| Interest Coverage Ratio: 4.64 > 6 (EBITDA TTM 20.34b / Interest Expense TTM 3.27b) |
Altman Z'' 1.83
| A: -0.02 (Total Current Assets 12.68b - Total Current Liabilities 14.52b) / Total Assets 109.29b |
| B: 0.21 (Retained Earnings 22.93b / Total Assets 109.29b) |
| C: 0.13 (EBIT TTM 15.16b / Avg Total Assets 114.33b) |
| D: 0.35 (Book Value of Equity 21.25b / Total Liabilities 61.15b) |
| Altman-Z'' Score: 1.83 = BBB |
Beneish M -3.00
| DSRI: 0.83 (Receivables 3.80b/3.64b, Revenue 51.48b/40.92b) |
| GMI: 0.99 (GM 83.17% / 82.07%) |
| AQI: 1.02 (AQ_t 0.84 / AQ_t-1 0.83) |
| SGI: 1.26 (Revenue 51.48b / 40.92b) |
| TATA: -0.01 (NI 10.83b - CFO 12.38b) / TA 109.29b) |
| Beneish M-Score: -3.00 (Cap -4..+1) = A |
What is the price of BTI shares?
As of March 26, 2026, the stock is trading at USD 58.45 with a total of 3,103,015 shares traded.
Over the past week, the price has changed by +0.62%, over one month by -7.27%, over three months by +3.42% and over the past year by +52.71%.
Over the past week, the price has changed by +0.62%, over one month by -7.27%, over three months by +3.42% and over the past year by +52.71%.
Is BTI a buy, sell or hold?
British American Tobacco has received a consensus analysts rating of 3.40.
Therefor, it is recommend to hold BTI.
- StrongBuy: 1
- Buy: 2
- Hold: 1
- Sell: 0
- StrongSell: 1
What are the forecasts/targets for the BTI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 60.9 | 4.2% |
| Analysts Target Price | 60.9 | 4.2% |
BTI Fundamental Data Overview March 21, 2026
Market Cap GBP = 95.67b (128.14b USD * 0.7466 USD.GBP)
P/E Trailing = 12.4936
P/E Forward = 11.8765
P/S = 5.0034
P/B = 1.9882
P/EG = 0.4154
Revenue TTM = 51.48b GBP
EBIT TTM = 15.16b GBP
EBITDA TTM = 20.34b GBP
Long Term Debt = 31.33b GBP (from longTermDebt, last quarter)
Short Term Debt = 3.36b GBP (from shortTermDebt, last quarter)
Debt = 35.07b GBP (from shortLongTermDebtTotal, last quarter)
Net Debt = 31.24b GBP (from netDebt column, last quarter)
Enterprise Value = 126.90b GBP (95.67b + Debt 35.07b - CCE 3.84b)
Interest Coverage Ratio = 4.64 (Ebit TTM 15.16b / Interest Expense TTM 3.27b)
EV/FCF = 8.29x (Enterprise Value 126.90b / FCF TTM 15.31b)
FCF Yield = 12.06% (FCF TTM 15.31b / Enterprise Value 126.90b)
FCF Margin = 29.74% (FCF TTM 15.31b / Revenue TTM 51.48b)
Net Margin = 21.04% (Net Income TTM 10.83b / Revenue TTM 51.48b)
Gross Margin = 83.17% ((Revenue TTM 51.48b - Cost of Revenue TTM 8.66b) / Revenue TTM)
Gross Margin QoQ = 83.42% (prev 83.59%)
Tobins Q-Ratio = 1.16 (Enterprise Value 126.90b / Total Assets 109.29b)
Interest Expense / Debt = 2.18% (Interest Expense 764.0m / Debt 35.07b)
Taxrate = 25.32% (1.08b / 4.29b)
NOPAT = 11.32b (EBIT 15.16b * (1 - 25.32%))
Current Ratio = 0.87 (Total Current Assets 12.68b / Total Current Liabilities 14.52b)
Debt / Equity = 0.73 (Debt 35.07b / totalStockholderEquity, last quarter 47.93b)
Debt / EBITDA = 1.54 (Net Debt 31.24b / EBITDA 20.34b)
Debt / FCF = 2.04 (Net Debt 31.24b / FCF TTM 15.31b)
Total Stockholder Equity = 49.64b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.47% (Net Income 10.83b / Total Assets 109.29b)
RoE = 21.82% (Net Income TTM 10.83b / Total Stockholder Equity 49.64b)
RoCE = 18.72% (EBIT 15.16b / Capital Employed (Equity 49.64b + L.T.Debt 31.33b))
RoIC = 19.42% (NOPAT 11.32b / Invested Capital 58.27b)
WACC = 4.77% (E(95.67b)/V(130.74b) * Re(5.92%) + D(35.07b)/V(130.74b) * Rd(2.18%) * (1-Tc(0.25)))
Discount Rate = 5.92% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.92%
Shares Correlation 3-Years: -100.0 | Cagr: -0.84%
[DCF] Terminal Value 87.46% ; FCFF base≈15.34b ; Y1≈17.31b ; Y5≈23.39b
[DCF] Fair Price = 302.2 (EV 686.21b - Net Debt 31.24b = Equity 654.97b / Shares 2.17b; r=6.0% [WACC]; 5y FCF grow 14.95% → 3.0% )
EPS Correlation: 10.99 | EPS CAGR: 1.74% | SUE: 0.00 | # QB: 0
Revenue Correlation: 84.76 | Revenue CAGR: 23.76% | SUE: N/A | # QB: 0
EPS current Year (2026-12-31): EPS=4.95 | Chg7d=+0.000 | Chg30d=+0.079 | Revisions Net=+1 | Growth EPS=+3.1% | Growth Revenue=+3.0%
EPS next Year (2027-12-31): EPS=5.33 | Chg7d=-0.008 | Chg30d=-0.018 | Revisions Net=+0 | Growth EPS=+7.5% | Growth Revenue=+3.4%
[Analyst] Revisions Ratio: +1.00 (1 Up / 0 Down within 30d for Current Year)
[Growth] Implied Growth Rate = -0.1% (Discount Rate 7.9% - Earnings Yield 8.0%)
[Growth] Growth Spread = +3.4% (Analyst 3.4% - Implied -0.1%)
P/E Trailing = 12.4936
P/E Forward = 11.8765
P/S = 5.0034
P/B = 1.9882
P/EG = 0.4154
Revenue TTM = 51.48b GBP
EBIT TTM = 15.16b GBP
EBITDA TTM = 20.34b GBP
Long Term Debt = 31.33b GBP (from longTermDebt, last quarter)
Short Term Debt = 3.36b GBP (from shortTermDebt, last quarter)
Debt = 35.07b GBP (from shortLongTermDebtTotal, last quarter)
Net Debt = 31.24b GBP (from netDebt column, last quarter)
Enterprise Value = 126.90b GBP (95.67b + Debt 35.07b - CCE 3.84b)
Interest Coverage Ratio = 4.64 (Ebit TTM 15.16b / Interest Expense TTM 3.27b)
EV/FCF = 8.29x (Enterprise Value 126.90b / FCF TTM 15.31b)
FCF Yield = 12.06% (FCF TTM 15.31b / Enterprise Value 126.90b)
FCF Margin = 29.74% (FCF TTM 15.31b / Revenue TTM 51.48b)
Net Margin = 21.04% (Net Income TTM 10.83b / Revenue TTM 51.48b)
Gross Margin = 83.17% ((Revenue TTM 51.48b - Cost of Revenue TTM 8.66b) / Revenue TTM)
Gross Margin QoQ = 83.42% (prev 83.59%)
Tobins Q-Ratio = 1.16 (Enterprise Value 126.90b / Total Assets 109.29b)
Interest Expense / Debt = 2.18% (Interest Expense 764.0m / Debt 35.07b)
Taxrate = 25.32% (1.08b / 4.29b)
NOPAT = 11.32b (EBIT 15.16b * (1 - 25.32%))
Current Ratio = 0.87 (Total Current Assets 12.68b / Total Current Liabilities 14.52b)
Debt / Equity = 0.73 (Debt 35.07b / totalStockholderEquity, last quarter 47.93b)
Debt / EBITDA = 1.54 (Net Debt 31.24b / EBITDA 20.34b)
Debt / FCF = 2.04 (Net Debt 31.24b / FCF TTM 15.31b)
Total Stockholder Equity = 49.64b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.47% (Net Income 10.83b / Total Assets 109.29b)
RoE = 21.82% (Net Income TTM 10.83b / Total Stockholder Equity 49.64b)
RoCE = 18.72% (EBIT 15.16b / Capital Employed (Equity 49.64b + L.T.Debt 31.33b))
RoIC = 19.42% (NOPAT 11.32b / Invested Capital 58.27b)
WACC = 4.77% (E(95.67b)/V(130.74b) * Re(5.92%) + D(35.07b)/V(130.74b) * Rd(2.18%) * (1-Tc(0.25)))
Discount Rate = 5.92% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.92%
Shares Correlation 3-Years: -100.0 | Cagr: -0.84%
[DCF] Terminal Value 87.46% ; FCFF base≈15.34b ; Y1≈17.31b ; Y5≈23.39b
[DCF] Fair Price = 302.2 (EV 686.21b - Net Debt 31.24b = Equity 654.97b / Shares 2.17b; r=6.0% [WACC]; 5y FCF grow 14.95% → 3.0% )
EPS Correlation: 10.99 | EPS CAGR: 1.74% | SUE: 0.00 | # QB: 0
Revenue Correlation: 84.76 | Revenue CAGR: 23.76% | SUE: N/A | # QB: 0
EPS current Year (2026-12-31): EPS=4.95 | Chg7d=+0.000 | Chg30d=+0.079 | Revisions Net=+1 | Growth EPS=+3.1% | Growth Revenue=+3.0%
EPS next Year (2027-12-31): EPS=5.33 | Chg7d=-0.008 | Chg30d=-0.018 | Revisions Net=+0 | Growth EPS=+7.5% | Growth Revenue=+3.4%
[Analyst] Revisions Ratio: +1.00 (1 Up / 0 Down within 30d for Current Year)
[Growth] Implied Growth Rate = -0.1% (Discount Rate 7.9% - Earnings Yield 8.0%)
[Growth] Growth Spread = +3.4% (Analyst 3.4% - Implied -0.1%)